Fierce Pharma February 3, 2023
By Max Bayer, Fraiser Kansteiner

J&J’s pharmaceutical changes come as the company spins off its consumer healthcare group into a separate company called Kenvue. (BSR Agency/Getty Images News)

Three Johnson & Johnson pharmaceutical executives stood before a group of staff in the R&D unit Wednesday, joking about expensive Uber rides and one “phenomenal dinner” at a Japanese steakhouse while attending the J.P. Morgan Healthcare Conference in San Francisco in early January.

But just minutes earlier, the mood was anything but jovial, as the leaders explained to a nervous group of employees in the Janssen pharmaceutical unit an overhaul of operations for the infectious diseases and vaccine groups, with sweeping layoffs expected to claim staffers’ jobs in countries around the world. Some staff...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech
How our genome is like a generative AI model
Can Pfizer, Sangamo energise haemophilia A gene therapy?
Contributed Content: 2 Alternatives to Ineffective Prescription Drug Rebates
Pharma Pulse 7/25/24: Driving CAR-Ts for Treatment in Cancer and Immunology, CrowdStrike Explains What Went Wrong in Global Outage & more
Roche says it’ll move quickly with ‘differentiated’ obesity drugs

Share This Article